Inappropriate metformin prescribing in elderly type 2 diabetes mellitus (T2DM) patients.

作者: M Kosmalski , A Drozdowska , A Sliwinska , J Drzewoski

DOI: 10.2478/V10039-012-0017-7

关键词: Medical historyDiabetes mellitusType 2 Diabetes MellitusMedicineMedical prescriptionPharmacologyMetforminPhysical examinationInternal medicineTolerabilityAdverse effect

摘要: ABSTRACT Purpose Metformin is the most commonly prescribed anti-diabetic medication. However, it often used despite presence of contraindications and in unlicensed indications. The main aim this study was to evaluate frequency metformin use before hospitalization spite patients with type 2 diabetes mellitus (T2DM) prevalence - associated side effects. Material/Methods 558 hospitalized (mean age = 66.65±12.73 years) poorly controlled T2DM were enrolled. Detailed medical history including duration T2DM, hypoglycemic agents usage prior possible metformin-associated effects recorded. Patients subjected a thorough physical examination indispensable biochemical diagnostic research panel performed establish degree heart failure, sufficiency respiratory system kidney function. Results 335 out treated alone or combination other agents, mostly sulfonylureas. Contraindications found 275 120 them using medication an average dose 1793.91±701.61 mg. none reported any serious adverse no significant pH changes observed. Only three moderate dyspepsia. Conclusions results indicate relatively good tolerability by traditional drug. These findings support authors’ suggestion that indications should be re-evaluated.

参考文章(26)
D. R. Cryer, S. P. Nicholas, D. H. Henry, D. J. Mills, B. V. Stadel, Comparative Outcomes Study of Metformin Intervention Versus Conventional Approach The COSMIC Approach Study Diabetes Care. ,vol. 28, pp. 539- 543 ,(2005) , 10.2337/DIACARE.28.3.539
J. McCormack, Metformin's contraindications should be contraindicated Canadian Medical Association Journal. ,vol. 173, pp. 502- 504 ,(2005) , 10.1503/CMAJ.045292
A. M. Emslie-Smith, D. I. R. Boyle, J. M. M. Evans, F. Sullivan, A. D. Morris, , Contraindications to metformin therapy in patients with Type 2 diabetes--a population-based study of adherence to prescribing guidelines. Diabetic Medicine. ,vol. 18, pp. 483- 488 ,(2001) , 10.1046/J.1464-5491.2001.00509.X
Juraporn Pongwecharak, Nawatsanan Tengmeesri, Nongluck Malanusorn, Matshamon Panthong, Nantida Pawangkapin, Prescribing metformin in type 2 diabetes with a contraindication: prevalence and outcome Pharmacy World & Science. ,vol. 31, pp. 481- 486 ,(2009) , 10.1007/S11096-009-9303-2
C. Lamanna, M. Monami, N. Marchionni, E. Mannucci, Effect of metformin on cardiovascular events and mortality: a meta‐analysis of randomized clinical trials Diabetes, Obesity and Metabolism. ,vol. 13, pp. 221- 228 ,(2011) , 10.1111/J.1463-1326.2010.01349.X
Helen J Nye, William G Herrington, None, Metformin: The Safest Hypoglycaemic Agent in Chronic Kidney Disease? Nephron Clinical Practice. ,vol. 118, ,(2011) , 10.1159/000323739
M. Stang, D. K. Wysowski, D. Butler-Jones, Incidence of lactic acidosis in metformin users. Diabetes Care. ,vol. 22, pp. 925- 927 ,(1999) , 10.2337/DIACARE.22.6.925
Amy T. Calabrese, Kim C. Coley, Stacey V. DaPos, Dennis Swanson, R. Harsha Rao, Evaluation of prescribing practices: risk of lactic acidosis with metformin therapy. JAMA Internal Medicine. ,vol. 162, pp. 434- 437 ,(2002) , 10.1001/ARCHINTE.162.4.434